VentriPoint Diagnostics Ltd. (VPTDF)
USD 0.1
(4.95%)
USD 0.1
(4.95%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.88 Million CAD | -68.49% |
| 2022 | 5.97 Million CAD | -37.38% |
| 2021 | 9.54 Million CAD | 1090.77% |
| 2020 | 801.57 Thousand CAD | 155.05% |
| 2019 | 314.28 Thousand CAD | -32.63% |
| 2018 | 466.48 Thousand CAD | -72.72% |
| 2017 | 1.7 Million CAD | 154.27% |
| 2016 | 672.5 Thousand CAD | -69.15% |
| 2015 | 2.17 Million CAD | 343.26% |
| 2014 | 491.73 Thousand CAD | -35.36% |
| 2013 | 760.72 Thousand CAD | -35.25% |
| 2012 | 1.17 Million CAD | -51.91% |
| 2011 | 2.44 Million CAD | 43.6% |
| 2010 | 1.7 Million CAD | 727.09% |
| 2009 | 205.68 Thousand CAD | -46.96% |
| 2008 | 387.79 Thousand CAD | -87.5% |
| 2007 | 3.1 Million CAD | 356.17% |
| 2006 | 679.97 Thousand CAD | -3.01% |
| 2005 | 701.04 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 670.51 Thousand CAD | -21.45% |
| 2024 Q1 | 853.64 Thousand CAD | -54.67% |
| 2023 Q2 | 3.88 Million CAD | -19.94% |
| 2023 FY | 1.88 Million CAD | -68.49% |
| 2023 Q4 | 1.88 Million CAD | -35.42% |
| 2023 Q3 | 2.91 Million CAD | -24.96% |
| 2023 Q1 | 4.85 Million CAD | -18.78% |
| 2022 Q1 | 8.65 Million CAD | -9.35% |
| 2022 Q4 | 5.97 Million CAD | -8.66% |
| 2022 Q2 | 7.65 Million CAD | -11.54% |
| 2022 Q3 | 6.54 Million CAD | -14.51% |
| 2022 FY | 5.97 Million CAD | -37.38% |
| 2021 Q2 | 3.61 Million CAD | 28.11% |
| 2021 FY | 9.54 Million CAD | 1090.77% |
| 2021 Q4 | 9.54 Million CAD | 195.8% |
| 2021 Q3 | 3.22 Million CAD | -10.81% |
| 2021 Q1 | 2.82 Million CAD | 252.32% |
| 2020 Q1 | 429.17 Thousand CAD | 36.56% |
| 2020 Q4 | 801.57 Thousand CAD | 56.65% |
| 2020 Q2 | 380.78 Thousand CAD | -11.27% |
| 2020 FY | 801.57 Thousand CAD | 155.05% |
| 2020 Q3 | 511.7 Thousand CAD | 34.38% |
| 2019 Q3 | 494.54 Thousand CAD | -21.11% |
| 2019 Q4 | 314.28 Thousand CAD | -36.45% |
| 2019 Q1 | 1.17 Million CAD | 152.39% |
| 2019 FY | 314.28 Thousand CAD | -32.63% |
| 2019 Q2 | 626.86 Thousand CAD | -46.76% |
| 2018 Q2 | 890.54 Thousand CAD | -26.49% |
| 2018 Q1 | 1.21 Million CAD | -29.16% |
| 2018 Q4 | 466.48 Thousand CAD | -59.38% |
| 2018 FY | 466.48 Thousand CAD | -72.72% |
| 2018 Q3 | 1.14 Million CAD | 28.96% |
| 2017 FY | 1.7 Million CAD | 154.27% |
| 2017 Q4 | 1.7 Million CAD | -33.27% |
| 2017 Q3 | 2.56 Million CAD | -25.77% |
| 2017 Q2 | 3.45 Million CAD | -12.01% |
| 2017 Q1 | 3.92 Million CAD | 483.36% |
| 2016 Q1 | 1.17 Million CAD | -45.98% |
| 2016 FY | 672.5 Thousand CAD | -69.15% |
| 2016 Q4 | 672.5 Thousand CAD | 29.37% |
| 2016 Q3 | 519.84 Thousand CAD | -29.07% |
| 2016 Q2 | 732.91 Thousand CAD | -37.75% |
| 2015 Q1 | 464.63 Thousand CAD | -5.51% |
| 2015 Q2 | 669.07 Thousand CAD | 44.0% |
| 2015 Q3 | 2.65 Million CAD | 296.58% |
| 2015 FY | 2.17 Million CAD | 343.26% |
| 2015 Q4 | 2.17 Million CAD | -17.86% |
| 2014 Q2 | 1.4 Million CAD | 167.43% |
| 2014 Q1 | 525.89 Thousand CAD | -30.87% |
| 2014 FY | 491.73 Thousand CAD | -35.36% |
| 2014 Q4 | 491.73 Thousand CAD | -42.01% |
| 2014 Q3 | 848.03 Thousand CAD | -39.7% |
| 2013 FY | 760.72 Thousand CAD | -35.25% |
| 2013 Q4 | 760.72 Thousand CAD | -30.53% |
| 2013 Q3 | 1.09 Million CAD | 21.65% |
| 2013 Q2 | 900.13 Thousand CAD | -22.92% |
| 2013 Q1 | 1.16 Million CAD | -0.6% |
| 2012 FY | 1.17 Million CAD | -51.91% |
| 2012 Q4 | 1.17 Million CAD | -47.94% |
| 2012 Q1 | 1.29 Million CAD | -47.02% |
| 2012 Q3 | 2.25 Million CAD | -26.22% |
| 2012 Q2 | 3.05 Million CAD | 136.37% |
| 2011 Q2 | 1.51 Million CAD | 30.22% |
| 2011 Q4 | 2.44 Million CAD | -14.24% |
| 2011 FY | 2.44 Million CAD | 43.6% |
| 2011 Q1 | 1.16 Million CAD | -31.58% |
| 2011 Q3 | 2.84 Million CAD | 87.94% |
| 2010 Q4 | 1.7 Million CAD | 845.44% |
| 2010 Q3 | 179.93 Thousand CAD | -71.94% |
| 2010 FY | 1.7 Million CAD | 727.09% |
| 2010 Q2 | 641.35 Thousand CAD | -49.42% |
| 2010 Q1 | 1.26 Million CAD | 516.5% |
| 2009 FY | 205.68 Thousand CAD | -46.96% |
| 2009 Q3 | 317.35 Thousand CAD | 10.88% |
| 2009 Q1 | 562.25 Thousand CAD | 44.99% |
| 2009 Q2 | 286.2 Thousand CAD | -49.1% |
| 2009 Q4 | 205.68 Thousand CAD | -35.19% |
| 2008 Q2 | 1.41 Million CAD | -43.28% |
| 2008 Q3 | 564.61 Thousand CAD | -60.16% |
| 2008 FY | 387.79 Thousand CAD | -87.5% |
| 2008 Q4 | 387.79 Thousand CAD | -31.32% |
| 2008 Q1 | 2.49 Million CAD | -19.44% |
| 2007 FY | 3.1 Million CAD | 356.17% |
| 2007 Q4 | 3.1 Million CAD | -26.94% |
| 2007 Q3 | 4.24 Million CAD | 511.66% |
| 2007 Q2 | 694.09 Thousand CAD | 7.38% |
| 2007 Q1 | 646.41 Thousand CAD | -4.93% |
| 2006 Q4 | 679.97 Thousand CAD | -1.69% |
| 2006 Q3 | 691.62 Thousand CAD | 0.19% |
| 2006 Q1 | 691.22 Thousand CAD | 0.0% |
| 2006 FY | 679.97 Thousand CAD | -3.01% |
| 2006 Q2 | 690.31 Thousand CAD | -0.13% |
| 2005 FY | 701.04 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | -7.756% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -116.289% |
| Polarean Imaging plc | 10.86 Million USD | 82.669% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 999 Thousand USD | -88.527% |
| BioElectronics Corporation | 144.38 Thousand USD | -1204.392% |
| AVITA Medical, Inc. | 144.33 Million USD | 98.695% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -496.008% |
| Össur hf. | 1.39 Billion USD | 99.865% |
| Zecotek Photonics Inc. | 2.57 Million USD | 26.799% |
| QHSLab, Inc. | 1.68 Million USD | -12.011% |
| Wellstar International, Inc. | 957.89 Thousand USD | -96.618% |
| Össur hf. | 1.39 Billion USD | 99.865% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 98.17% |
| Escalon Medical Corp. | 4.75 Million USD | 60.416% |
| Aurora Spine Corporation | 11.92 Million USD | 84.205% |
| BrainsWay Ltd. | 62.97 Million USD | 97.009% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | 33.987% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 98.29% |
| Vivos Inc. | 1.61 Million USD | -16.971% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.952% |
| Kelyniam Global, Inc. | 1.63 Million USD | -15.354% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -56.127% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -3340.098% |
| Nanomix Corporation | 982.05 Thousand USD | -91.78% |
| Theraclion SA | 18.66 Million EUR | 89.909% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -933.804% |
| Positron Corporation | 1.76 Million USD | -6.547% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -151.661% |
| Lombard Medical, Inc. | 67.76 Million USD | 97.221% |
| ALR Technologies Inc. | 193.21 Thousand USD | -874.751% |
| Stratec SE | 529.71 Million USD | 99.644% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -89.8% |
| Heart Tronics, Inc. | 4.04 Million USD | 53.484% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 14.857% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 90.831% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 91.598% |
| VMS Rehab Systems, Inc. | 4.45 USD | -42323158.427% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -12.845% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -155.292% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -313.211% |
| United American Healthcare Corporation | 10.37 Million USD | 81.854% |
| ECGI Holdings, Inc. | 5.2 Million USD | 63.791% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -5473.134% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 11.939% |
| Urologix, Inc. | 5.66 Million USD | 66.766% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 16.464% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 90.746% |
| SS Innovations International, Inc. | 25.47 Million USD | 92.608% |
| Qualis Innovations, Inc. | 2431.00 USD | -77373.673% |
| Smith & Nephew plc | 9.97 Billion USD | 99.981% |
| NIOX Group Plc | 116.47 Million USD | 98.383% |
| Fuse Medical, Inc. | 16.25 Million USD | 88.416% |
| Broncus Holding Corporation | 195.75 Million USD | 99.038% |
| Brain Scientific Inc. | 11.74 Million USD | 83.962% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -79.425% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -6454.324% |